Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Hiligsmann, Mickaël; Reginster, Jean-Yves
2010 • In Value in Health, 13 (7), p. 309
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/70150
DOI
10.1016/S1098-3015(11)72193-3
 

Files (2)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Abstract_ISPOR2010.pdf
Author postprint (15.2 kB)
Request a copy
Annexes
ISPOR_2010_Dmab.pdf
Publisher postprint (633.56 kB)
Présentation Poster
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Research Center/Unit :
Unité de Recherches en Pharmaco-Economie (ECOHEALTH)
Disciplines :
Special economic topics (health, labor, transportation...)
Endocrinology, metabolism & nutrition
Author, co-author :
Hiligsmann, Mickaël ;  Université de Liège - ULiège > HEC-Ecole de gestion
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Publication date :
November 2010
Event name :
ISPOR 13th Annual European Congress
Event organizer :
ISPOR
Event place :
Prague, Czechia
Event date :
du 6 novembre 2010 au 9 novembre 2009
Audience :
International
Journal title :
Value in Health
ISSN :
1098-3015
eISSN :
1524-4733
Publisher :
Blackwell Publishing, Oxford, United Kingdom
Volume :
13
Issue :
7
Pages :
A309
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 August 2010

Statistics

Number of views
121 (8 by ULiège)
Number of downloads
2 (2 by ULiège)
More statistics
OpenCitations
 
1
OpenAlex citations
 
2

Bibliography

Similar publications


Contact ORBi